View Older Stories View More Recent Stories

May 20, 2026 09:00AM Research Alliance Corporation III prices $75 million IPO at $10 per share
May 15, 2026 04:51PM Form SCHEDULE 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:49PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:47PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:47PM Form SCHEDULE 13G/A Invivyd, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:46PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:44PM Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:43PM Form SCHEDULE 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:42PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:41PM Form SCHEDULE 13G Atrium Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:36PM Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 04:34PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 15, 2026 09:00AM Sana Biotechnology raises $69 million through share sale
May 14, 2026 05:24PM Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 13, 2026 05:48PM Form SCHEDULE 13D/A Artiva Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 11, 2026 05:46PM Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P.
May 8, 2026 06:52AM Artiva Biotherapeutics prices $300 million stock and warrant offering
May 1, 2026 04:11PM Form SCHEDULE 13G Altimmune, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 29, 2026 06:44PM Form SCHEDULE 13D/A Climb Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 28, 2026 05:16PM Form SCHEDULE 13G Prelude Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 28, 2026 07:00AM Climb Bio raises $110 million in private placement
Apr 27, 2026 04:46PM Form SCHEDULE 13G JATT II Acquisition Corp Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 27, 2026 07:00AM Altimmune closes $225 million public offering for liver drug development
Apr 23, 2026 06:56PM Form SCHEDULE 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 21, 2026 07:06PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 20, 2026 06:31AM Prelude Therapeutics prices $90 million stock offering at $4.44 per share
Apr 17, 2026 04:57PM Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 17, 2026 08:00AM Tyra Biosciences appoints Habib Dable to board of directors
Apr 15, 2026 05:31PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 14, 2026 02:08PM Galera and Obsidian merge in $350 million all-stock deal
Apr 14, 2026 08:54AM Obsidian Therapeutics and Galera Therapeutics announce merger with $350M funding
Apr 13, 2026 05:23PM Form SCHEDULE 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2026 06:25PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 8, 2026 06:45PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 7, 2026 06:00PM Form SCHEDULE 13G Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 7, 2026 04:14PM Form SCHEDULE 13G OnKure Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 6, 2026 06:55PM Form SCHEDULE 13G Zai Lab Ltd Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 2, 2026 04:47PM Form SCHEDULE 13G Karyopharm Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 1, 2026 05:10PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 1, 2026 07:05AM Cyclerion and Korsana announce $380 million merger deal
Mar 30, 2026 08:38PM Form SCHEDULE 13G Xencor Inc Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 30, 2026 08:32PM Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 27, 2026 08:02AM OnKure raises $150 million to advance cancer treatment programs
Mar 24, 2026 07:02AM Karyopharm raises $30 million in private placement with RA Capital
Mar 23, 2026 04:28PM Form SCHEDULE 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 23, 2026 04:26PM Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 20, 2026 04:13PM Form SCHEDULE 13G Equillium, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 18, 2026 06:00AM Ovid Therapeutics prices $60 million private placement for drug development
Mar 17, 2026 06:50PM Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 17, 2026 04:36PM Form SCHEDULE 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
View More Recent Stories View Older Stories